Becton Dickinson and (NYSE:BDX) Price Target Lowered to $285.00 at Wells Fargo & Co
Becton Dickinson and (NYSE:BDX) had its price target lowered by Wells Fargo & Co from $290.00 to $285.00 in a research note issued to investors on Wednesday, Stock Target Advisor reports. The firm currently has an outperform rating on the medical instruments supplier’s stock.
BDX has been the topic of a number of other reports. Morgan Stanley increased their target price on shares of Becton Dickinson and from $250.00 to $261.00 and gave the stock an equal weight rating in a report on Tuesday, July 16th. ValuEngine lowered shares of Becton Dickinson and from a buy rating to a hold rating in a report on Thursday, August 1st. Finally, Piper Jaffray Companies reduced their target price on shares of Becton Dickinson and from $267.00 to $266.00 and set an overweight rating on the stock in ...